Yip Lab

Research Focus Teams: Cancer, Rare Diseases

Lab Team

Dr. Calvin Yip
Calvin Yip

Professor

add

CONTACT

Profile
Samples in the lab being handled.
Alex Shaw

PhD Student

Samples in the lab being handled.
Alice Liu

Honours Thesis Student

Samples in the lab being handled.
Chase Talarico

MSc Student

Samples in the lab being handled.
Chloe House

MSc Student

Samples in the lab being handled.
Elijah Hoy

PhD Student

Samples in the lab being handled.
Hannah Shariati

PhD Student

Samples in the lab being handled.
Kelly Ye

Work Learn Student

Samples in the lab being handled.
Kha Nguyen

PhD Student

Samples in the lab being handled.
Rachel Wang

Directed Studies Student

Samples in the lab being handled.
Sunny Cheung

Postdoctoral Fellow, Yip Lab

Samples in the lab being handled.
Tomas Pelletier

PhD Student

Ongoing Projects

chevron_left
chevron_right

Autophagy machinery

How does a cell remove and recycle unwanted materials? Autophagy is an evolutionarily conserved pathway that encapsulates large objects to be degraded in a double-membrane vesicle called the autophagosome and targets this cargo to the lysosome for breakdown. Defects in this pathway have been implicated in neurodegenerative disorders, cancers, and other human diseases. We study how a specialized group of proteins that mediate the different steps of this important degradative pathway using biochemical, structural biology, and cell biology approaches.
Autophagy machinery

Chromatin modifying complexes

How does a cell establishes and maintains its gene expression pattern and adapts this to different environmental conditions? Eukaryotic genomic DNA exists in a DNA-protein complex known as chromatin. Post translational modifications to the histone proteins that form the nucleosome, the most basic unit of chromatin, is a key mechanism to regulate chromatin structure and gene expression. Using budding yeast as a model, we study how specialized multi-protein chromatin modifying complexes in this organism perform their physiological functions using biochemical and structural biology approaches.
Chromatin modifying complexes

Rare genetic diseases

There are over 7,000 different types of rare diseases. It is estimated that 1 in 12 Canadians is affected by a rare disease. Although the genetic bases of many of these diseases have been uncovered, the molecular mechanism of how these genetic changes lead to severe clinical phenotypes remains undefined. We are applying biochemical, structural, and cell biology approaches to address this problem, with an emphasis on the severe multi-system disorder Vici syndrome (https://vicisyndrome.org).
Rare genetic diseases